{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:35:19Z","timestamp":1792931719972,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["30C"],"award-info":[{"award-number":["30C"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["30D"],"award-info":[{"award-number":["30D"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.redox.2026.104420","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:27:20Z","timestamp":1790699240000},"page":"104420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["NEURL1-mediated K63-ubiquitination of SLC40A1 drives ferroptosis resistance in pathological scars: Therapeutic targeting via autophagy-activating microneedles"],"prefix":"10.1016","volume":"97","author":[{"given":"Mengzhu","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianlong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2026.104420_bib1","first-page":"64","article-title":"Scars. Nature reviews","volume":"9","author":"Jeschke","year":"2023","journal-title":"Dis. Prim."},{"key":"10.1016\/j.redox.2026.104420_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamadermatol.2022.5607","article-title":"Comorbidities of keloid and hypertrophic scars among participants in UK biobank","volume":"159","author":"Ung","year":"2023","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.redox.2026.104420_bib3","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/jdv.17484","article-title":"Treatment of keloids and hypertrophic scars. Position statement of the Brazilian expert group GREMCIQ","volume":"35","author":"Oliveira","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol. : JEADV"},{"key":"10.1016\/j.redox.2026.104420_bib4","article-title":"Laser therapy for treating hypertrophic and keloid scars","volume":"9","author":"Leszczynski","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.redox.2026.104420_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40257-022-00744-6","article-title":"Hypertrophic scars and keloids: advances in treatment and review of established therapies","volume":"24","author":"Frech","year":"2023","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.redox.2026.104420_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108528","article-title":"Novel approaches to target fibroblast mechanotransduction in fibroproliferative diseases","volume":"250","author":"Ezzo","year":"2023","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.redox.2026.104420_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102509","article-title":"Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model","volume":"57","author":"Pei","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104420_bib8","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41419-022-05515-z","article-title":"UHRF1-mediated ferroptosis promotes pulmonary fibrosis via epigenetic repression of GPX4 and FSP1 genes","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2026.104420_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103029","article-title":"Salvianolic acid B attenuates liver fibrosis by targeting Ecm1 and inhibiting hepatocyte ferroptosis","volume":"69","author":"Fu","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104420_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-024-02078-0","article-title":"Emerging roles of ferroptosis in pulmonary fibrosis: current perspectives, opportunities and challenges","volume":"10","author":"Hu","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.redox.2026.104420_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-024-02181-2","article-title":"Repair and regeneration: ferroptosis in the process of remodeling and fibrosis in impaired organs","volume":"10","author":"Yin","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.redox.2026.104420_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cmet.2005.01.003","article-title":"The iron exporter ferroportin\/Slc40a1 is essential for iron homeostasis","volume":"1","author":"Donovan","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2026.104420_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-024-06902-4","article-title":"Erianin induces ferroptosis in GSCs via REST\/LRSAM1 mediated SLC40A1 ubiquitination to overcome TMZ resistance","volume":"15","author":"Mansuer","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2026.104420_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102435","article-title":"Ferroportin-dependent ferroptosis induced by ellagic acid retards liver fibrosis by impairing the SNARE complexes formation","volume":"56","author":"Li","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104420_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tips.2023.12.003","article-title":"Tumor iron homeostasis and immune regulation","volume":"45","author":"Zhang","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.redox.2026.104420_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41581-023-00689-x","article-title":"Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney","volume":"19","author":"Bay\u0131r","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.redox.2026.104420_bib17","article-title":"Ferroptosis: a new mechanism of traditional Chinese medicine compounds for treating acute kidney injury","volume":"163","author":"Shi","year":"2023","journal-title":"Biomed. Pharmacother.= Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.redox.2026.104420_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151770","article-title":"The role of JPX in regulating FUS\/SLC7A11 signaling pathway mediated ferroptosis in keloid fibroblasts and its potential in scar repair","volume":"763","author":"Tang","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2026.104420_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.freeradbiomed.2024.05.013","article-title":"Upregulation of GPX4 drives ferroptosis resistance in scleroderma skin fibroblasts","volume":"221","author":"Zhang","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2026.104420_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115496","article-title":"The ferroptosis-associated gene TIMP1 facilitates skin scar formation through the interaction with CST3 in fibroblasts","volume":"165","author":"He","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.redox.2026.104420_bib21","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/CM9.0000000000002784","article-title":"Role of ferroptosis in fibrosis: from mechanism to potential therapy","volume":"137","author":"Qiu","year":"2023","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.redox.2026.104420_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109812","article-title":"The emerging roles of ferroptosis in organ fibrosis and its potential therapeutic effect","volume":"116","author":"Huang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.redox.2026.104420_bib23","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s00204-024-03745-y","article-title":"Targeted ferritinophagy in gastrointestinal cancer: from molecular mechanisms to implications","volume":"98","author":"Feng","year":"2024","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.redox.2026.104420_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101670","article-title":"Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis","volume":"36","author":"Fuhrmann","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104420_bib25","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s12035-023-03640-0","article-title":"Mechanisms of ferritinophagy and ferroptosis in diseases","volume":"61","author":"Li","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.redox.2026.104420_bib26","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1002\/ptr.8220","article-title":"Curcumin and its anti-colorectal cancer potential: from mechanisms of action to autophagy","volume":"38","author":"Brockmueller","year":"2024","journal-title":"Phytother Res. : PTR"},{"key":"10.1016\/j.redox.2026.104420_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102703","article-title":"The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1","volume":"62","author":"Cheff","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2026.104420_bib28","doi-asserted-by":"crossref","DOI":"10.1007\/s10571-024-01459-4","article-title":"Iron deposition in parkinson's disease: a mini-review","volume":"44","author":"Zeng","year":"2024","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.redox.2026.104420_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102575","article-title":"Iron homeostasis and neurodegeneration in the ageing brain: insight into ferroptosis pathways","volume":"102","author":"Alrouji","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.redox.2026.104420_bib30","article-title":"<scp>SLC40A1<\/scp> in iron metabolism, ferroptosis, and disease: a review","volume":"16","author":"Zhang","year":"2024","journal-title":"WIREs Mech. Dis."},{"key":"10.1016\/j.redox.2026.104420_bib31","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1080\/15548627.2024.2340413","article-title":"Transformation of autophagic SQSTM1 droplets to SQSTM1-dependent P-bodies","volume":"20","author":"Valionyte","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2026.104420_bib32","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41418-022-00942-z","article-title":"Palmitoylation restricts SQSTM1\/p62-mediated autophagic degradation of NOD2 to modulate inflammation","volume":"29","author":"Zhou","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.redox.2026.104420_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/15548627.2024.2394308","article-title":"TRIM21-mediated ubiquitination of SQSTM1\/p62 abolishes its Ser403 phosphorylation and enhances palmitic acid cytotoxicity","volume":"21","author":"Yang","year":"2025","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2026.104420_bib34","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1080\/15548627.2023.2297623","article-title":"S-acylation regulates SQSTM1\/p62-mediated selective autophagy","volume":"20","author":"Huang","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2026.104420_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113935","article-title":"Discovery of SQSTM1\/p62-dependent P-bodies that regulate the NLRP3 inflammasome","volume":"43","author":"Barrow","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.redox.2026.104420_bib36","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1089\/ars.2018.7649","article-title":"p62\/SQSTM1 and selective autophagy in cardiometabolic diseases","volume":"31","author":"Jeong","year":"2019","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2026.104420_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-43069-x","article-title":"Neuralized family member NEURL1 is a ubiquitin ligase for the cGMP-specific phosphodiesterase 9A","volume":"9","author":"Taal","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2026.104420_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102279","article-title":"Ubiquitin E3 ligases assisted technologies in protein degradation: sharing pathways in neurodegenerative disorders and cancer","volume":"96","author":"Kaushik","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.redox.2026.104420_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216065","article-title":"PROTACs: promising approach for anticancer therapy","volume":"556","author":"Kaur","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.redox.2026.104420_bib40","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.scib.2024.03.056","article-title":"Targeting the undruggables\u2014the power of protein degraders","volume":"69","author":"Zhang","year":"2024","journal-title":"Sci. Bullet."},{"key":"10.1016\/j.redox.2026.104420_bib41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s43188-024-00236-1","article-title":"Lysine-63-linked polyubiquitination: a principal target of cadmium carcinogenesis","volume":"40","author":"Chargui","year":"2024","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.redox.2026.104420_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128201","article-title":"Snakehead vesiculovirus hijacks SH3RF1 for replication via mediating K63-linked ubiquitination at K264 of the phosphoprotein","volume":"255","author":"Qin","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.redox.2026.104420_bib43","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.18632\/aging.102710","article-title":"K63 ubiquitin chains target NLRP3 inflammasome for autophagic degradation in ox-LDL-stimulated THP-1 macrophages","volume":"12","author":"Zhou","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.redox.2026.104420_bib44","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1716673115","article-title":"K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains","volume":"115","author":"Ohtake","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.redox.2026.104420_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/5162256","article-title":"The Spectra of disease-causing mutations in the Ferroportin 1 (SLC40A1) encoding gene and related Iron overload phenotypes (Hemochromatosis type 4 and Ferroportin disease)","author":"Uguen","year":"2023","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.redox.2026.104420_bib46","article-title":"Structural basis of K11\/K48-branched ubiquitin chain recognition by the human 26S proteasome","author":"Draczkowski","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.redox.2026.104420_bib47","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.tibs.2024.06.011","article-title":"Ubiquitin system mutations in neurological diseases","volume":"49","author":"Zenge","year":"2024","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.redox.2026.104420_bib48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41580-024-00778-0","article-title":"Mechanisms and regulation of substrate degradation by the 26S proteasome","volume":"26","author":"Arkinson","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.redox.2026.104420_bib49","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3390\/antiox12081604","article-title":"Fibrosis development linked to alterations in glucose and energy metabolism and prooxidant\u2013antioxidant balance in experimental models of liver injury","volume":"12","author":"Semenovich","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2026.104420_bib50","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/antiox9121279","article-title":"Molecular mechanisms that link oxidative stress, inflammation, and fibrosis in the liver","volume":"9","author":"Ramos-Tovar","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2026.104420_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115109","article-title":"Strategies to develop polymeric microneedles for controlled drug release","volume":"203","author":"Chen","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.redox.2026.104420_bib52","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3349\/ymj.2022.0092","article-title":"Microneedle transdermal drug delivery systems for allergen-specific immunotherapy, skin disease treatment, and vaccine development","volume":"63","author":"Park","year":"2022","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.redox.2026.104420_bib53","doi-asserted-by":"crossref","first-page":"368","DOI":"10.69613\/6fp5f839","article-title":"A review on microneedle-based transdermal drug delivery systems","volume":"3","author":"Pinnamraju","year":"2025","journal-title":"J. Pharma Insights Res."},{"key":"10.1016\/j.redox.2026.104420_bib54","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1002\/jcp.29302","article-title":"Molecular mechanism of myofibroblast formation and strategies for clinical drugs treatments in hypertrophic scars","volume":"235","author":"Zhu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.redox.2026.104420_bib55","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.3892\/mmr.2017.6437","article-title":"Expression of TGF-\u03b21\/mTOR signaling pathway in pathological scar fibroblasts","volume":"15","author":"Zhai","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.redox.2026.104420_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-023-02037-4","article-title":"Nano drug delivery systems: a promising approach to scar prevention and treatment","volume":"21","author":"Ding","year":"2023","journal-title":"J. Nanobiotechnol."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726004192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726004192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T12:17:38Z","timestamp":1792930658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231726004192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"alternative-id":["S2213231726004192"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104420","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NEURL1-mediated K63-ubiquitination of SLC40A1 drives ferroptosis resistance in pathological scars: Therapeutic targeting via autophagy-activating microneedles","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104420"}}